ID

20085

Descrizione

An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: AVA100468, Sponsor: GSK

Keywords

versioni (2)
  1. 02/02/17 02/02/17 -
  2. 06/02/17 06/02/17 -
Caricato su

6 febbraio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Running Logs Serious Adverse Events GSK-AVA100468 NCT00381238

Inglese

Running Logs Serious Adverse Events GSK-AVA100468 NCT00381238

1 moduli  
Serious Adverse Event
Descrizione

Serious Adverse Event

Alias
UMLS CUI-1
C1519255
Event (diagnosis only, otherwise sign/symptom)
Descrizione

Event

Tipo di dati

text

Alias
UMLS CUI [1]
C1519255
Start Date
Descrizione

Start Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1519255
Outcome
Descrizione

Outcome

Tipo di dati

integer

Alias
UMLS CUI [1]
C1705586
End Date
Descrizione

End Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1519255
Maximum Intensity
Descrizione

Maximum Intensity

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0518690
UMLS CUI [1,2]
C1519255
Action Taken with Investigational Product(s) as a Result of the Serious AE
Descrizione

Investigational product(s) withdrawn = Administration of investigational product(s) was permanently discontinued. Dose reduced = Dose is reduced for one or more investigational product(s). Dose increased = Dose increased for one or more investigational product(s). Dose not changed = Investigational product(s) continues even though an adverse event has occured. Dose interrupted = Administration of one or more investigational product(s) was stopped temporarily but then restarted. Not applicable = Subject was not receiving investigational product(s) when the event occurred (e.g., pre- or post-dosing).

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C1704758
UMLS CUI [1,2]
C1519255
Did the subject withdraw from study as a result of this SAE?
Descrizione

Withdrawal

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1519255
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descrizione

Relationship to investigational products

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1519255
Seriousness
Descrizione

Seriousness

Alias
UMLS CUI-1
C0871902
UMLS CUI-2
C1519255
Seriousness: Specify reason(s) for considering this a SAE, tick all that apply:
Descrizione

Seriousness

Tipo di dati

integer

Alias
UMLS CUI [1]
C1710056
Seriousness: If other, specify:
Descrizione

Seriousness Other

Tipo di dati

text

Alias
UMLS CUI [1]
C1710056
Demography Data
Descrizione

Demography Data

Alias
UMLS CUI-1
C1704791
Date of birth
Descrizione

Date of birth

Tipo di dati

date

Alias
UMLS CUI [1]
C0421451
Sex
Descrizione

Sex

Tipo di dati

integer

Alias
UMLS CUI [1]
C0079399
Weight
Descrizione

Weight

Tipo di dati

float

Unità di misura
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Investigational Product
Descrizione

Investigational Product

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1519255
If Investigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were Administered?
Descrizione

Investigational Product

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1519255
Cause of SAE
Descrizione

Cause of SAE

Alias
UMLS CUI-1
C0015127
UMLS CUI-2
C1519255
Possible Cause of SAE other than investigational Product(s), tick all that apply:
Descrizione

Possible Cause of SAE

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C1519255
Possible Cause of SAE other than investigational Product(s), if other, specify:
Descrizione

Possible Cause of SAE Other

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C1519255
Relevant Medical Conditions
Descrizione

Relevant Medical Conditions

Alias
UMLS CUI-1
C0262926
Specify any RELEVANT past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE
Descrizione

medical condition

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C1519255
Date of Onset
Descrizione

medical condition date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C1519255
Condition present at the time of the SAE?
Descrizione

medical condition presence

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C1519255
If no, Date of last occurence:
Descrizione

medical condition occurence

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C1519255
Risk Factors
Descrizione

Risk Factors

Alias
UMLS CUI-1
C0035648
Other RELEVANT Risk Factors (e.g. smoking, alcohol, diet, drug abuse, accupational hazard) relevant to the SAE
Descrizione

Risk Factors

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0035648
UMLS CUI [1,2]
C1519255
Concomitant medications
Descrizione

Concomitant medications

Alias
UMLS CUI-1
C2347852
Drug name (Trade Name preferred)
Descrizione

Drug name

Tipo di dati

text

Alias
UMLS CUI [1]
C0013227
Dose
Descrizione

Dose

Tipo di dati

text

Alias
UMLS CUI [1]
C3174092
Unit
Descrizione

Unit

Tipo di dati

text

Alias
UMLS CUI [1]
C1519795
Frequency
Descrizione

Medication frequency

Tipo di dati

text

Alias
UMLS CUI [1]
C3476109
Route
Descrizione

Route

Tipo di dati

text

Alias
UMLS CUI [1]
C0013153
Taken Prior to Study?
Descrizione

Taken Prior to Study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826667
Start Date
Descrizione

Start Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C2347852
Stop Date
Descrizione

Stop Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C2347852
Ongoing Medication?
Descrizione

Ongoing Medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2826666
Reason for Medication (e.g. Gastric Ulcer)
Descrizione

Reason for Medication

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013227
Investigational Product
Descrizione

Investigational Product

Alias
UMLS CUI-1
C0304229
Details of Investigational Product(s)
Descrizione

Investigational Product

Tipo di dati

text

Alias
UMLS CUI [1]
C0304229
Was randomisation code broken at investigational site?
Descrizione

Investigational Product randomisation

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0034656
Assessments
Descrizione

Assessments

Alias
UMLS CUI-1
C0220825
Details of RELEVANT assessments.
Descrizione

Assessment

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1516048
UMLS CUI [1,2]
C1519255
Narrative Remarks
Descrizione

Narrative Remarks

Alias
UMLS CUI-1
C0947611
Narrative Remarks (provide a brief narrative description of the SAE and details of tretment given).
Descrizione

Narrative Remarks

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C1519255
Ritorna all'inizio della pagina

Similar models

Running Logs Serious Adverse Events GSK-AVA100468 NCT00381238

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Serious Adverse Event
C1519255 (UMLS CUI-1)
Event
Item
Event (diagnosis only, otherwise sign/symptom)
text
C1519255 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not Recovered/Not Resolved (3)
End Date
Item
End Date
date
C0806020 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item
Maximum Intensity
integer
C0518690 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Maximum Intensity
Code List
Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (4)
Item
Action Taken with Investigational Product(s) as a Result of the Serious AE
integer
C1704758 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Action Taken with Investigational Product
Code List
Action Taken with Investigational Product(s) as a Result of the Serious AE
CL Item
Investigational product(s) withdrawn  (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (6)
Withdrawal
Item
Did the subject withdraw from study as a result of this SAE?
boolean
C2349954 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Relationship to investigational products
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0085978 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Seriousness
C0871902 (UMLS CUI-1)
C1519255 (UMLS CUI-2)
Item
Seriousness: Specify reason(s) for considering this a SAE, tick all that apply:
integer
C1710056 (UMLS CUI [1])
Seriousness
Code List
Seriousness: Specify reason(s) for considering this a SAE, tick all that apply:
CL Item
Results in death (1)
CL Item
Is life-threatening (2)
CL Item
Requires hospitalisation or prolongation of existing hospitalisation (3)
CL Item
Results in disability/incapacity (4)
CL Item
Congenital anomaly/birth defect (5)
CL Item
Other (6)
Seriousness Other
Item
Seriousness: If other, specify:
text
C1710056 (UMLS CUI [1])
Item Group
Demography Data
C1704791 (UMLS CUI-1)
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Sex
integer
C0079399 (UMLS CUI [1])
Sex
Code List
Sex
CL Item
Male (1)
CL Item
Female (2)
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
C1519255 (UMLS CUI-2)
Item
If Investigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were Administered?
integer
C0304229 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Investigational Product
Code List
If Investigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were Administered?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Item Group
Cause of SAE
C0015127 (UMLS CUI-1)
C1519255 (UMLS CUI-2)
Item
Possible Cause of SAE other than investigational Product(s), tick all that apply:
integer
C0015127 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Possible Cause of SAE
Code List
Possible Cause of SAE other than investigational Product(s), tick all that apply:
CL Item
Disease under study (1)
CL Item
Medical Condition(s) (record in nect section) (2)
CL Item
Lack of efficacy (3)
CL Item
Withdrawal of Investigational Product(s) (4)
CL Item
Concomitant medication (record) (5)
CL Item
Activity related to study participation (e.g. procedures) (6)
CL Item
Other (7)
Possible Cause of SAE Other
Item
Possible Cause of SAE other than investigational Product(s), if other, specify:
text
C0015127 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Relevant Medical Conditions
C0262926 (UMLS CUI-1)
medical condition
Item
Specify any RELEVANT past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE
text
C0262926 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
medical condition date
Item
Date of Onset
date
C0012634 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
medical condition presence
Item
Condition present at the time of the SAE?
boolean
C0012634 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
medical condition occurence
Item
If no, Date of last occurence:
date
C0012634 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
Item Group
Risk Factors
C0035648 (UMLS CUI-1)
Risk Factors
Item
Other RELEVANT Risk Factors (e.g. smoking, alcohol, diet, drug abuse, accupational hazard) relevant to the SAE
text
C0035648 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Concomitant medications
C2347852 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Dose
Item
Dose
text
C3174092 (UMLS CUI [1])
Unit
Item
Unit
text
C1519795 (UMLS CUI [1])
Medication frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Taken Prior to Study
Item
Taken Prior to Study?
boolean
C2826667 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Ongoing Medication
Item
Ongoing Medication?
boolean
C2826666 (UMLS CUI [1])
Reason for Medication
Item
Reason for Medication (e.g. Gastric Ulcer)
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Investigational Product
Item
Details of Investigational Product(s)
text
C0304229 (UMLS CUI [1])
Item
Was randomisation code broken at investigational site?
integer
C0304229 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Investigational Product randomisation
Code List
Was randomisation code broken at investigational site?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not applicable (3)
Item Group
Assessments
C0220825 (UMLS CUI-1)
Assessment
Item
Details of RELEVANT assessments.
text
C1516048 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
Narrative Remarks
C0947611 (UMLS CUI-1)
Narrative Remarks
Item
Narrative Remarks (provide a brief narrative description of the SAE and details of tretment given).
text
C0947611 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial